500 related articles for article (PubMed ID: 15893376)
21. The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
Paterson NE; Balci F; Campbell U; Olivier BE; Hanania T
J Psychopharmacol; 2011 Oct; 25(10):1357-64. PubMed ID: 20305042
[TBL] [Abstract][Full Text] [Related]
22. Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases.
O'Donnell JM; Frith S
Pharmacol Biochem Behav; 1999 May; 63(1):185-92. PubMed ID: 10340540
[TBL] [Abstract][Full Text] [Related]
23. Effects of antidepressants in rats trained to discriminate centrally administered isoproterenol.
Crissman AM; O'Donnell JM
J Pharmacol Exp Ther; 2002 Aug; 302(2):606-11. PubMed ID: 12130722
[TBL] [Abstract][Full Text] [Related]
24. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
25. The quetiapine active metabolite N-desalkylquetiapine and the neurotensin NTS₁ receptor agonist PD149163 exhibit antidepressant-like effects on operant responding in male rats.
Hillhouse TM; Shankland Z; Matazel KS; Keiser AA; Prus AJ
Exp Clin Psychopharmacol; 2014 Dec; 22(6):548-56. PubMed ID: 25285844
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.
Taylor DP; Carter RB; Eison AS; Mullins UL; Smith HL; Torrente JR; Wright RN; Yocca FD
J Clin Psychiatry; 1995; 56 Suppl 6():3-11. PubMed ID: 7649970
[TBL] [Abstract][Full Text] [Related]
27. Effects of amphetamine on differential reinforcement of low rates of responding.
Saulsgiver KA; McClure EA; Wynne CD
Behav Pharmacol; 2007 Mar; 18(2):119-33. PubMed ID: 17351419
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
29. Can the DRL 72s schedule selectively reveal antidepressant drug activity?
Jackson A; Koek W; Colpaert FC
Psychopharmacology (Berl); 1995 Jan; 117(2):154-61. PubMed ID: 7753961
[TBL] [Abstract][Full Text] [Related]
30. The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat.
Ardayfio PA; Benvenga MJ; Chaney SF; Love PL; Catlow J; Swanson SP; Marek GJ
J Pharmacol Exp Ther; 2008 Dec; 327(3):891-7. PubMed ID: 18772320
[TBL] [Abstract][Full Text] [Related]
31. Potential antidepressant properties of pramipexole detected in locomotor and operant behavioral investigations in mice.
Lehr E
Psychopharmacology (Berl); 2002 Oct; 163(3-4):495-500. PubMed ID: 12373450
[TBL] [Abstract][Full Text] [Related]
32. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
33. Serotonergic mediation of DRL 72s behavior: receptor subtype involvement in a behavioral screen for antidepressant drugs.
Jolly DC; Richards JB; Seiden LS
Biol Psychiatry; 1999 May; 45(9):1151-62. PubMed ID: 10331107
[TBL] [Abstract][Full Text] [Related]
34. Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine.
Li AA; Marek GJ; Hand TH; Seiden LS
Eur J Pharmacol; 1990 Feb; 177(3):137-44. PubMed ID: 2311675
[TBL] [Abstract][Full Text] [Related]
35. Antidepressant-like and anxiolytic-like actions of the mGlu5 receptor antagonist MTEP, microinjected into lateral septal nuclei of male Wistar rats.
Molina-Hernández M; Tellez-Alcántara NP; Pérez-García J; Olivera-Lopez JI; Jaramillo MT
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1129-35. PubMed ID: 16759778
[TBL] [Abstract][Full Text] [Related]
36. Effects of caffeine and PD 116,600 on the differential-reinforcement-of-low rate 72-S (DRL 72-S) schedule of reinforcement.
Marek GJ; Heffner TG; Richards JB; Shaughnessy RA; Li AA; Seiden LS
Pharmacol Biochem Behav; 1993 Aug; 45(4):987-90. PubMed ID: 8415842
[TBL] [Abstract][Full Text] [Related]
37. Effects of salbutamol upon performance on an operant screen for antidepressants.
Dunn RT; Richards JB; Seiden LS
Psychopharmacology (Berl); 1993; 113(1):1-10. PubMed ID: 7862813
[TBL] [Abstract][Full Text] [Related]
38. The relationship between the locomotor response to a novel environment and behavioral disinhibition in rats.
Stoffel EC; Cunningham KA
Drug Alcohol Depend; 2008 Jan; 92(1-3):69-78. PubMed ID: 17997051
[TBL] [Abstract][Full Text] [Related]
39. Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol.
O'Donnell JM
J Pharmacol Exp Ther; 1990 Jul; 254(1):147-57. PubMed ID: 1973194
[TBL] [Abstract][Full Text] [Related]
40. Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
Bespalov AY; van Gaalen MM; Sukhotina IA; Wicke K; Mezler M; Schoemaker H; Gross G
Eur J Pharmacol; 2008 Sep; 592(1-3):96-102. PubMed ID: 18634781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
